BDTX Stock Analysis: Buy, Sell, or Hold?
BDTX - Black Diamond Therapeutics, Inc. Common Stock
$2.39
0.06 (2.58%)
▲
5d:
+12.21%
30d:
-2.85%
90d:
-1.65%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
BDTX is down 3.6% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 17 OI. Call ratio: 100% View Scanner →
Strength: 6.8/10
Get Alerted When BDTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BDTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: BDTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: BDTX is currently trading at $2.39, which is considered slightly high relative to its 30-day fair value range of $2.09 to $2.40.
Technical Outlook: Technically, BDTX is in a strong downtrend. Immediate support is located at $2.00, while resistance sits at $2.49.
Market Sentiment: BDTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.71 (+306.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BDTX is in a strong downtrend. Immediate support is located at $2.00, while resistance sits at $2.49.
Market Sentiment: BDTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.71 (+306.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.09 -
$2.40
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 306.5% below Wall St target ($9.71)
Fair Price Analysis
30-Day Fair Range
$2.09 -
$2.40
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.00
Resistance Level
$2.49
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.32
Wall Street Target
$9.71
(+306.5%)
Profit Margin
31.9%
Share & Embed Analysis
Last updated: April 03, 2026 4:59 AM ET
Data refreshes hourly during market hours. Next update: 5:59 AM
Data refreshes hourly during market hours. Next update: 5:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 65 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 61 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 61 BUY |
